Increasing benefit, reducing risk: focusing on hemorrhagic complications in percutaneous coronary intervention.
Aguirre
Frank V
FV
Prairie Cardiovascular Consultants, Ltd., Southern Illinois University School of Medicine, Springfield, Illinois, USA.
Gill
John B
JB
D015906:Angioplasty, Balloon, Coronary; D000925:Anticoagulants / Q000009:adverse effects; D001777:Blood Coagulation / Q000187:drug effects; D003327:Coronary Disease / Q000150:complications / Q000601:surgery; D004305:Dose-Response Relationship, Drug; D006493:Heparin / Q000009:adverse effects; D006801:Humans; D019060:Minimally Invasive Surgical Procedures; D010346:Patient Care Management; D018579:Patient Selection; D015539:Platelet Activation / Q000187:drug effects; D019106:Postoperative Hemorrhage / Q000453:epidemiology / Q000209:etiology* / Q000451:nursing; D011237:Predictive Value of Tests; D016032:Randomized Controlled Trials as Topic; D051437:Renal Insufficiency / Q000209:etiology; D012307:Risk Factors; D017211:Treatment Failure
D000925:Anticoagulants; D006493:Heparin